GLP ‐1 receptor agonists alleviate colonic inflammation by modulating intestinal microbiota and the function of group 3 innate lymphoid cells
Immunology · 2024-07 · 172 (3) · 451-468
DOI: 10.1111/imm.13784 ↗At a glance
Journal article in Immunology, published online on 2024-03-27. Written by Hanxiao Sun and 12 co-authors. Institution: Department of Clinical Laboratory, The Second Hospital of Shandong University, Jinan, Shandong, China. Major MEDLINE topics: Gastrointestinal Microbiome, Colitis, Glucagon-Like Peptide-1 Receptor, Immunity, Innate. Cited 63 times so far (Crossref); 48 references. Funded by: National Natural Science Foundation of China, Shanghai Outstanding Academic Leader Science and Technology Program, Changning District Master Doctor Innovative Talent Base.
Abstract (original language)
Glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs), which are drugs used for treating type 2 diabetes, have been reported to exert anti‐inflammatory effects on inflammatory bowel disease (IBD), the mechanism of which remains elusive. Here, we report that GLP‐1RAs ameliorate dextran sulfate sodium (DSS)‐induced colitis in both wild‐type and T/B‐cell‐deficient mice through modulating group 3 innate lymphoid cells (ILC3s), a subset of innate lymphoid cells that regulate intestinal immunity. GLP‐1RAs promote IL‐22 production by ILC3, and the protective effect of GLP‐1RAs on DSS‐induced colitis was abrogated in ILC3‐deficient RORgt gfp/gfp mice. Furthermore, the treatment effect of GLP‐RAs on colitis, as well as the generation of IL‐22‐producing ILC3s by GLP‐RAs, is dependent on the gut microbiota. GLP‐1RAs increase the abundance of Firmicutes and Proteobacteria in the gut, particularly beneficial bacteria such as Lactobacillus reuteri, and decrease the abundance of enteropathogenic Staphylococcus bacteria. The untargeted gas chromatography (GC)/liquid chromatography (LC)‐mass spectrometry (MS) of faecal metabolites further revealed enrichment of N,N‐dimethylsphingosine (DMS), an endogenous metabolite derived from sphingosine, in the GLP‐1RA‐treated group. Strikingly, DMS ameliorates colitis while promoting intestinal IL‐22‐producing ILC3s. Taken together, our findings show that GLP‐1RAs exert a therapeutic effect on colitis possibly by regulating the microbiota‐DMS‐IL‐22 + ILC3 axis, highlighting the potential beneficial role of GLP‐RAs in inflammatory intestinal disorders with diabetes complications.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Clinical Laboratory, The Second Hospital of Shandong University, Jinan, Shandong, China.
- Department of Laboratory Medicine, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China.
ORCID profiles: Hanxiao Sun, Ju Qiu
Funding
- National Natural Science Foundation of China
- Shanghai Outstanding Academic Leader Science and Technology Program
- Changning District Master Doctor Innovative Talent Base
- Shanghai Jiao Tong University Key Project of Medical Engineering
- Project of Changning District Health Commission
- Youth Project of Changning District Health Commission
- Firefly Project Plan of Tongren Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
- Shanghai Science and Technology Committee (STCSM)
Cite
APA
Sun, H., Shu, J., Tang, J., Li, Y., Qiu, J., Ding, Z., Xuan, B., Chen, M., Gan, C., Lin, J., Qiu, J., Sheng, H., & Wang, C. (2024). GLP ‐1 receptor agonists alleviate colonic inflammation by modulating intestinal microbiota and the function of group 3 innate lymphoid cells. Immunology, 172(3), 451-468. https://doi.org/10.1111/imm.13784
Vancouver
Sun H, Shu J, Tang J, Li Y, Qiu J, Ding Z, et al. GLP ‐1 receptor agonists alleviate colonic inflammation by modulating intestinal microbiota and the function of group 3 innate lymphoid cells. Immunology. 2024;172(3):451-468. doi:10.1111/imm.13784
BibTeX
@article{Sun2024,
author = {Sun, Hanxiao and Shu, Jie and Tang, Jupei and Li, Yue and Qiu, Jinxin and Ding, Zhaoyun and Xuan, Binbin and Chen, Minghui and Gan, Chenxin and Lin, Jinpiao and Qiu, Ju and Sheng, Huiming and Wang, Chuanxin},
title = {GLP ‐1 receptor agonists alleviate colonic inflammation by modulating intestinal microbiota and the function of group 3 innate lymphoid cells},
journal = {Immunology},
year = {2024},
volume = {172},
number = {3},
pages = {451--468},
doi = {10.1111/imm.13784}
}
EUVIMED